NLRP3 and COVID-19: Anakinra inhibited NLRP3 inflammasome-dependent pyroptosis, alleviated the lung pathology, and eventually reduced the mortality in the SASR-CoV-2-infected mice model.176 A variety of clinical studies evaluating the effects of anakinra for COVID-19 treatment have been conducted.